[1]彭李博综述,王建东审校.受体酪氨酸激酶Eph基因表达与人类结直肠癌的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):48-51.

点击复制

受体酪氨酸激酶Eph基因表达与人类结直肠癌的研究进展()

分享到62.8K

参考文献/References:

[1]Hirai H,Maru Y,Hagiwara K,et al.A novel putative tyrosine kinase receptor encoded by the Eph gene[J].Science， 1987,238(4834):1717-1720.
[2]Pasquale E B.Eph-Ephrin bidirectional signaling in physiology and disease[J].Cell， 2008,133(1):38-52.
[3]Batlle E,Henderson J T,Beghtel H,et al.Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB[J].Cell， 2002,111(2):251-263.
[4]Migani P,Bartlett C,Dunlop S,et al.Regional and cellular distribution of Ephrin B1 in adult mouse brain[J].Brain Res， 2009,1247:50-61.
[5]Saito T,Masuda N,Miyazaki T,et al.Expression of Eph A2 and E-cadherin in colorectal cancer:correlation with cancer metastasis[J].Oncol Rep， 2004,11(3):605-611.
[6]Dong Y,Wang J,Sheng Z,et al.Downregulation of Eph A1 in colorectal carcinomas correlates with invasion and metastasis[J].Mod Pathol， 2009,22(1):151-160.
[7]Herath NI,Doecke J,Spanevello MD,et al.Epigenetic silencing of Eph A1 expression in colorectal cancer is correlated with poor survival[J].Br J Cancer， 2009,100(7):1095-1102.
[8]Wang J,Kataoka H,Suzuki M,et al.Downregulation of Eph A7 by hypermethylation in colorectal cancer[J].Oncogene， 2005,24(36):5637-5647.
[9]王建东，王绪林，董迎春，等.TaqMan探针检测结直肠癌血浆中微量甲基化Eph A7基因[J].东南国防医药， 2009，11(2):97-99.
[10]Xi HQ,Zhao P.Clinicopathological significance and prognostic value of Eph A3 and CD133 expression in colorectal carcinoma[J].J Clin Pathol， 2011,64(6):498-503.
[11]Oshima T,Akaike M,Yoshihara K,et al.Overexpression of Eph A4 gene and reduced expression of Eph B2 gene correlates with liver metastasis in colorectal cancer[J].Int J Oncol， 2008,33(3):573-577.
[12]Brantley-Sieders DM.Clinical relevance of Ephs and Ephrins in cancer:lessons from breast,colorectal,and lung cancer profiling[J].Semin Cell Dev Biol， 2012,23(1):102-108.
[13]Martiny-Baron G,Korff T,Schaffner F,et al.Inhibition of tumor growth and angiogenesis by soluble Eph B4[J].Neoplasia， 2004,6(3):248-257.
[14]Batlle E,Bacani J,Begthel H,et al.Eph B receptor activity suppresses colorectal cancer progression[J].Nature， 2005,435(7045):1126-1130.
[15]Clevers H,Batlle E.Eph B/Ephrin B receptors and wnt signaling in colorectal cancer[J].Cancer Res， 2006,66(1):2-5.
[16]Guo D L,Zhang J,Yuen S T,et al.Reduced expression of Eph B2 that parallels invasion and metastasis in colorectal tumours[J].Carcinogenesis， 2006,27(3):454-464.
[17]Merlos-Suarez A,Barriga FM,Jung P,et al.The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse[J].Cell Stem Cell， 2011,8(5):511-524.
[18]Senior PV,Zhang BX,Chan ST.Loss of cell-surface receptor Eph B2 is important for the growth,migration,and invasiveness of a colon cancer cell line[J].Int J Colorectal Dis， 2010,25(6):687-694.
[19]Sheng Z,Wang J,Dong Y,et al.Eph B1 is underexpressed in poorly differentiated colorectal cancers[J].Pathobiology， 2008,75(5):274-280.
[20]Chiu ST,Chang KJ,Ting CH,et al.Over-expression of Eph B3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells[J].Carcinogenesis， 2009,30(9):1475-1486.
[21]Kumar SR,Scehnet JS,Ley EJ,et al.Preferential induction of Eph B4 over Eph B2 and its implication in colorectal cancer progression[J].Cancer Res， 2009,69(9):3736-3745.
[22]Yamaguchi S,Tatsumi T,Takehara T,et al.Immunotherapy of murine colon cancer using receptor tyrosine kinase Eph A2-derived peptide-pulsed dendritic cell vaccines[J].Cancer， 2007,110(7):1469-1477.
[23]Xia G,Kumar SR,Masood R,et al.Up-regulation of Eph B4 in mesothelioma and its biological significance[J].Clin Cancer Res， 2005,11(12):4305-4315.
[24]Abengozar MA,de Frutos S,Ferreiro S,et al.Blocking Ephrin B2 with highly specific antibodies inhibits angiogenesis,lymphangiogenesis,and tumor growth[J].Blood， 2012,119(19):4565-4576.
[25]Lee JS,Kang Y,Kim JT,et al.The anti-angiogenic and anti-tumor activity of synthetic phenylpropenone derivatives is mediated through the inhibition of receptor tyrosine kinases[J].Eur J Pharmacol， 2012,677(1-3):22-30.
[26]Landen CN,Kinch MS,Sood AK.Eph A2 as a target for ovarian cancer therapy[J].Expert Opin Ther Targets， 2005,9(6):1179-1187.
[27]朱 役，贾绍昌，蔡 凯，等.靶向血管内皮生长因子的纳米颗粒制备及其对大肠癌细胞株SW620的作用[J].医学研究生学报，2011，24(10):19-22.

相似文献/References: